Market Tracker

07/26 4:11am ET

Medivation Inc (NASDAQ:MDVN)

63.11
Delayed Data
As of Jul 25
 +0.48 / +0.77%
Today’s Change
26.41
Today|||52-Week Range
63.35
+30.55%
Year-to-Date
What's in Store for these 5 Drug Stocks in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal
Jul 21 / TheStreet.com - Paid Partner Content
Benzinga's M&A Chatter for Thursday July 21, 2016:
Jul 21 / Benzinga - Paid Partner Content
3 Stocks That Turned $5,000 into $100,000 or More
Jul 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close62.63
Today’s open62.77
Day’s range62.05 - 63.16
Volume1,368,833
Average volume (3 months)3,246,948
Market cap$10.3B
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)-15.48%
Earnings growth (this year)-29.45%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+32.76%
P/E ratio41.5
Price/Sales8.68
Price/Book11.76

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...-1.24-2.32%
JAZZJazz Pharmaceuticals...-0.62-0.44%
IDXXIDEXX Laboratories I...-1.37-1.45%
VRXValeant Pharmaceutic...+0.03+0.13%
Data as of 07/25/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.22
Annual revenue (last year)$943.3M
Annual profit (last year)$244.7M
Net profit margin25.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David T. Hung
Chief Operating Officer
Marion McCourt
Corporate headquarters
San Francisco, California

Forecasts